Raymond James & Associates Staar Surgical CO Transaction History

Raymond James & Associates

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$39.39 - $58.12 $57,233 - $84,448	-1,453 Reduced 11.44%	11,243 $451,000
Q2 2023 Jul 25, 2023	SELL	$50.45 - $72.82 $222,131 - $320,626	-4,403 Reduced 25.75%	12,696 $667,000
Q1 2023 Apr 14, 2023	SELL	$51.25 - $79.34 $113,723 - $176,055	-2,219 Reduced 11.49%	17,099 $1.09 Million
Q4 2022 Feb 08, 2023	BUY	$46.82 - $76.2 $184,704 - $300,609	3,945 Added 25.66%	19,318 $937,000
Q3 2022 Oct 25, 2022	BUY	$70.55 - $111.58 $42,682 - $67,505	605 Added 4.1%	15,373 $1.09 Million
Q2 2022 Aug 12, 2022	BUY	$50.24 - $80.48 $103,695 - $166,110	2,064 Added 16.25%	14,768 $1.05 Million
Q1 2022 May 11, 2022	BUY	$57.98 - $93.5 $361,447 - $582,879	6,234 Added 96.35%	12,704 $1.02 Million
Q4 2021 Feb 08, 2022	SELL	$88.02 - $127.79 $347,414 - $504,387	-3,947 Reduced 37.89%	6,470 $591,000
Q3 2021 Nov 02, 2021	SELL	$122.75 - $162.68 $80,033 - $106,067	-652 Reduced 5.89%	10,417 $1.34 Million
Q2 2021 Aug 11, 2021	BUY	$105.76 - $154.96 $517,377 - $758,064	4,892 Added 79.2%	11,069 $1.69 Million
Q1 2021 May 14, 2021	SELL	$78.5 - $126.48 $165,321 - $266,366	-2,106 Reduced 25.43%	6,177 $651,000
Q4 2020 Feb 12, 2021	BUY	$55.93 - $82.78 $63,033 - $93,293	1,127 Added 15.75%	8,283 $656,000
Q3 2020 Nov 04, 2020	BUY	$45.65 - $61.81 $326,671 - $442,312	7,156 New	7,156 $405,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.